Study Status: Available
Recruit Status: Available
Study Type: Expanded Access
Official Title: Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
Brief Summary: This is an observational, open-label, flexible dose study that will prospectively and longitudinally assess the effect of Cannabidiol (CBD) therapy in patients with drug-resistant epilepsies through a Physician Expanded Access Investigational New Drug protocol.